Bright Horizons Family Solutions (BFAM) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
367
Total Shares Held
59.62M
Total Value
$6.75B
Institutional Holding %
102.69%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
Institution | Shares | Ownership % | Value |
---|---|---|---|
VANGUARD | 5.44M | 9.37% | $603.33M |
T. ROWE PRICE | 4.96M | 8.54% | $549.65M |
JPMorgan CHASE | 3.55M | 6.11% | $393.14M |
BlackRock | 3.39M | 5.84% | $376.12M |
KAYNE ANDERSON RUDNICK | 3.10M | 5.35% | $344.14M |
MASSACHUSETTS FINANCIALRVICES CO | 2.56M | 4.41% | $283.73M |
BROWNY | 2.47M | 4.25% | $273.50M |
WILLIAM BLAIR | 2.37M | 4.08% | $262.75M |
BAMCO | 1.56M | 2.69% | $172.85M |
CAPITAL WORLD INVESTORS | 1.35M | 2.33% | $149.77M |
Recent Insider Trading
Insider | Title | Transaction | Shares | Value | Date |
---|---|---|---|---|---|
Burke Mary Lou | Coo North America Center Ops | S-Sale | 1.00K | $126.54K | Apr 01, 2025 |
Burke Mary Lou | Coo North America Center Ops | S-Sale | 1.00K | $124.69K | Mar 13, 2025 |
Tocio Mary Ann | Director | S-Sale | 2.50K | $311.85K | Mar 10, 2025 |
Boland Elizabeth J | Chief Financial Officer | A-Award | 4.22K | $- | Mar 05, 2025 |
Boland Elizabeth J | Chief Financial Officer | S-Sale | 5.00K | $650.83K | Mar 05, 2025 |
Boland Elizabeth J | Chief Financial Officer | A-Award | 4.67K | $608.21K | Mar 05, 2025 |
Marshall Rosamund | Managing Director - Intl. | A-Award | 2.88K | $- | Mar 05, 2025 |
Marshall Rosamund | Managing Director - Intl. | A-Award | 3.19K | $414.72K | Mar 05, 2025 |
Burke Mary Lou | Coo North America Center Ops | A-Award | 4.22K | $- | Mar 05, 2025 |
Burke Mary Lou | Coo North America Center Ops | A-Award | 4.67K | $608.21K | Mar 05, 2025 |
Recent Position Changes
Institution | Shares Changed | % Change | Date |
---|---|---|---|
DURABLE | -3.00M | -69.63% | Feb 14, 2025 |
T. ROWE PRICE | +1.87M | +60.45% | Feb 14, 2025 |
PRICE T ROWE | -1.60M | -80.87% | Feb 14, 2025 |
ARTISANHIP | +825.76K | +100.00% | Feb 12, 2025 |
BlackRock | +766.49K | +29.18% | Feb 07, 2025 |
RAYMOND JAMES FINANCIAL | +717.89K | +100.00% | Feb 13, 2025 |
NORGES BANK | +648.10K | +100.00% | Feb 12, 2025 |
MASSACHUSETTS FINANCIALRVICES CO | -621.46K | -19.54% | Feb 12, 2025 |
WILLIAM BLAIR | +532.64K | +28.98% | Feb 10, 2025 |
JPMorgan CHASE | +511.90K | +16.87% | Feb 12, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 02, 2025
144
Form 144 - Report of proposed sale of securities
Apr 01, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 14, 2025
144
Form 144 - Report of proposed sale of securities
Mar 13, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 11, 2025
144
Form 144 - Report of proposed sale of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 07, 2025
144
Form 144 - Report of proposed sale of securities
Mar 05, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 27, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 19, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Dec 05, 2024
144
Form 144 - Report of proposed sale of securities
Dec 03, 2024
Related Metrics
Explore detailed financial metrics and analysis for BFAM.